Reaction Biology is a leading preclinical oncology CRO offering a comprehensive portfolio of in vivo services for drug discovery with a focus on the investigation of immune-modulating anti-cancer therapeutics. Our integrated cancer drug testing platform includes services for all steps of the drug discovery process, supporting the development of your preclinical candidate pipeline. Our scientists work as an extension of your team to expedite drug discovery projects by offering a full range of services including, biochemical assays against 1000+ targets, cell-based oncology assays, immuno-oncology & conventional tumor models, biophysical assays, and bioinformatics for in-depth characterization of your drug candidates.